After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Spyre Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Spyre Therapeutics Inc is $1.35B. A total of 0.56 million shares were traded on the day, compared to an average of 602.81K shares.
In the most recent transaction, Albers Jeffrey W. sold 6,700 shares of SYRE for 36.76 per share on Nov 06 ’24. After the transaction, the Director now owns 27,360 company shares. In a previous transaction on Oct 25 ’24, Albers Jeffrey W. sold 300 shares at 36.43 per share. SYRE shares that Director owns now total 34,060.
Among the insiders who bought shares, SESSIONS, LLC acquired of 7,000 shares on Oct 25 ’24 at a per-share price of $33.70. In another insider transaction, Burrows Scott L sold 18,531 shares at $28.17 per share on Sep 03 ’24. Company shares held by the Chief Financial Officer now total 116,422.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SYRE has a high of $47.97 and a low of $20.07.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SYRE’s latest balance sheet shows that the firm has $93.13M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $20.14M in liabilities at the time. Its Book Value Per Share was $3.34, while its Total Shareholder’s Equity was $83.94M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SYRE is Buy with a score of 4.82.
